Atlas maps plasma proteins to transform disease diagnosis and treatment

Researchers have developed the most comprehensive atlas linking plasma proteins to diseases and traits in over 53,000 individuals, offering groundbreaking insights for precision medicine. This resource uncovers 168,100 protein-disease associations and identifies new therapeutic targets.

Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets – Biotech Investments

EQS-News: Epigenomics AG / Key word(s): Strategic Company Decision/Contract Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets 24.07.2023 / 18:40 CET/CEST The

July 25, 2023

Do peripheral artery disease risk factors impact men and women differently?

How major risk factors relate to hospitalization or mortality.

October 20, 2023

European regulator recommends approval of Carvykti in earlier lines of multiple myeloma

A European Medicines Agency committee recommended that the label for Legend Biotech and Johnson & Johnson’s CAR-T Carvykti be expanded to multiple myeloma patients as

February 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.